The EEF1A2 International Registry is designed to allow information on patients with mutations in EEF1A2 to be collected together in one place. The more information we can compile, and the more consistency with which this information is put together, the better our chances of understanding how mutations in EEF1A2 cause epilepsy and intellectual disability.

We will be able to track outcomes, pull together information about which drugs help and which don’t, and ultimately design better therapeutic strategies and develop new drugs.